Drug-drug Interaction: Clinical Trials

39 trials for Drug-drug Interaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 5 unknown, 4 recruiting. 27 Phase 1, 3 Not applicable, 3 Phase 4, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 127Completed 25, Recruiting 1, Unknown 1
Not applicable3Completed 1, Recruiting 1, Unknown 1
Phase 43Completed 3
Early Phase 12Completed 1, Recruiting 1

Follow Drug-drug Interaction: new trials by email Literature Review of Drug-drug Interaction trials Research Report on Drug-drug Interaction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants
Aspirin, BAY3389934 - Drug-drug Interaction
Phase 1RecruitingBayer162026-05-292026-10-20
Pharmacokinetic Effect of Y-3 on Repaglinide,Warfarin and Omeprazole in Healthy Participants
sequentially single use of repaglinide, warfarin and omeprazole or combined with Y-3 - Pharmacokinetic Profiles, Y-3 for Injection
Phase 1CompletedNeurodawn Pharmaceutical Co., Ltd.242025-05-182026-05-22
Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV
Long-acting injectable cabotegravir (CAB-LA), No PrEP - HIV Infections, Contraception
RecruitingUniversity of Alabama at Birmingham1052025-01-242026-10-14
Determining the Clinical Relevance of the Interaction Between Enzalutamide and the Opioid Morphine and the DOAC Edoxaban
Blood sampling - Pharmacokinetic assessment - Drug-drug Interaction
UnknownRadboud University Medical Center262024-07-012022-10-27
Drug-drug Interactions With Anti-tuberculous Drugs
Anti Tuberculosis Drug - Drug-drug Interaction
UnknownCairo University4002024-04-302024-08-22
Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK
Methadone and Tizanidine, Efavirenz, Methadone and Tizanidine - Drug-Drug Interaction
Early Phase 1RecruitingIndiana University602023-10-062026-08-20
A DDI Study of JMKX000623 and Metformin Hydrochloride
JMKX000623, Metformin - Healthy, Drug-Drug Interaction
Phase 1CompletedJemincare242023-09-172024-04-25
Pharmaco-proteomic Platform to Evaluate Drug Interactions in Liver Transplant Patients
Multi-drug interaction - Drug-drug Interaction, Liver Transplantation
UnknownPontificia Universidad Catolica de Chile482023-06-012024-11-12
Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects
DWC202211 100mg, DWC202212 5mg, DWC202211 100mg + DWC202212 5mg - Drug-drug Interaction
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.242023-02-152023-04-04
A Study of PBI-200 With Ritonavir or Cobicistat in Healthy Volunteers
PBI-200 Tablet, Ritonavir Oral Tablet, Cobicistat Oral Tablet - Drug-drug Interaction
Phase 1CompletedPyramid Biosciences212022-09-092023-01-20
Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity
Givinostat 10 mg/mL, Midazolam 1mg/ml IV, Midazolam 2.5 mg oromucosal solution - Drug-Drug Interaction, Heathy Volunteer
Phase 1CompletedItalfarmaco262022-03-212025-01-06
The Effect of Dicloxacillin on Oral Absorption of Drugs
Dicloxacillin - Healthy Volunteers, Drug-drug Interaction
Phase 1CompletedUniversity of Southern Denmark122022-02-072022-07-21
Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin
Simvastatin, Voclosporin - Drug-drug Interaction
Phase 1CompletedAurinia Pharmaceuticals Inc.242022-01-242022-04-20
Kuwa Free! - Live Free!
Cabotegravir/ Rilpivirine, Etonogestrel (ETG) implant, Intramuscular depo-medroxyprogesterone acetate (IM DMPA) - HIV Infections, Contraception
Not applicableRecruitingUniversity of Alabama at Birmingham7002021-11-262026-04-13
Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa
Etonogestrel (ETG) implant, Intramuscular depo-medroxyprogesterone acetate (IM DMPA), Sub-cutaneous medroxyprogesterone acetate (SC MPA) - HIV Infections, Contraception
Phase 4CompletedUniversity of Alabama at Birmingham1102021-11-172025-04-08
Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
HBI-3000, Paroxetine - Drug-drug Interaction
Phase 1CompletedHUYABIO International, LLC.392021-02-212022-07-15
Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy
Dihydroartemisinin-piperaquine - Drug-Drug Interaction, HIV Infection
Phase 4CompletedUniversity of California, San Francisco1942020-11-232025-03-14
Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir
ZSP1273, Oseltamivir - Drug-drug Interaction
Phase 1CompletedGuangdong Raynovent Biotech Co., Ltd362020-11-192021-11-04
Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Lorecivivint (LOR), Triamcinolone acetonide (TA) - Drug-Drug Interaction
Phase 1CompletedBiosplice Therapeutics, Inc.402020-10-132021-01-12
Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers
DWC202005, alone, DWP14012 + DWC202005, DWP14012 + DWC202005, after multiple doses of DWP14012 - Drug-drug Interaction
Phase 1CompletedDaewoong Pharmaceutical Co. LTD.362020-09-062021-08-16

Showing 20 of 39. Sign in to see all of them.

Narrower conditions

HIV Infections (4)  ·  Inhibition, Psychological (2)  ·  Arthritis, Rheumatoid (1)  ·  Autoimmune Diseases (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Malaria (1)

Broader conditions

Immune System Diseases (6)  ·  Blood-Borne Infections (4)  ·  Communicable Diseases (4)  ·  Genital Diseases (4)  ·  Immunologic Deficiency Syndromes (4)  ·  Infections (4)  ·  Lentivirus Infections (4)  ·  RNA Virus Infections (4)  ·  Retroviridae Infections (4)  ·  Sexually Transmitted Diseases (4)  ·  Sexually Transmitted Diseases, Viral (4)  ·  Urogenital Diseases (4)  ·  Virus Diseases (4)  ·  Behavior (2)  ·  Arthritis (1)

Interventions

Omeprazole (4)  ·  Dabigatran (3)  ·  Itraconazole (3)  ·  Midazolam (3)  ·  Rifampin (3)  ·  Dipyrone (2)  ·  Gemfibrozil (2)  ·  Metformin (2)  ·  Paroxetine (2)  ·  efavirenz (2)  ·  etonogestrel (2)  ·  quizartinib (2)  ·  tucatinib (2)  ·  2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid (1)  ·  Antitubercular Agents (1)

Sponsors

University of Alabama at Birmingham (3)  ·  Daewoong Pharmaceutical Co. LTD. (2)  ·  Daiichi Sankyo Co., Ltd. (2)  ·  Seagen Inc. (2)  ·  University Hospital, Basel, Switzerland (2)  ·  University of California, San Francisco (2)  ·  Astellas Pharma Europe B.V. (1)  ·  AstraZeneca (1)  ·  Aurinia Pharmaceuticals Inc. (1)  ·  Bayer (1)  ·  Biosplice Therapeutics, Inc. (1)  ·  Boryung Pharmaceutical Co., Ltd (1)  ·  Cairo University (1)  ·  Genfit (1)  ·  Guangdong Raynovent Biotech Co., Ltd (1)

Countries

United States (14)  ·  China (4)  ·  Australia (3)  ·  France (3)  ·  South Korea (2)  ·  Switzerland (2)  ·  Botswana (1)  ·  Chile (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Kenya (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  South Africa (1)  ·  Turkey (Türkiye) (1)

Top investigators

Rena Patel, MD, MPH, MPhil (2)  ·  Adeodata Kekitiinwa (1)  ·  Alex Vo, PhD (1)  ·  Anna Wald, MD, MPH (1)  ·  Carlos Prendes, MD (1)  ·  Connie Davis, MD. (1)  ·  Edith Apondi (1)  ·  Edwin Were (1)  ·  Eun-Young Kim (1)  ·  Francesca Aweeka (1)  ·  Jason Lickliter, MBBS PhD FRACP (1)  ·  Jason Lickliter, MD (1)  ·  Jennifer Deering, MSN, ARNP (1)

Results publications

PMID 39368039, PMID 25929560, PMID 29746911, PMID 35931943, PMID 37124199, PMID 37645440, PMID 37902943, PMID 39992105, PMID 42081083, PMID 7758252

NIH funding

2018 (2), 2019 (2), R01AI155052 (2), P01GM032165 (1), R01HD068174 (1), R35GM145383 (1)